While Donald Trump’s claims of a landslide victory and a huge mandate in 2024 were always ridiculous, he did begin his second term with some of the highest job-approval ratings he’s ever had as ...

Approval ratings for public officials serve as a potentially crucial barometer of public sentiment, especially in an election cycle marked by economic anxieties and political turmoil. As Trump ...

American approval ratings of President Donald Trump, which have held relatively steady through deployments of the National Guard, unprecedented tariffs and the delayed release of the Epstein files, ...

President Donald Trump's approval rating has turned negative in the Republican-leaning states of Ohio and Iowa. Poll aggregators show Trump's national approval rating is net negative but has slightly ...

Ohio, which solidified itself as a red state in recent presidential elections, has flipped its approval rating of President Donald Trump, according to a recent report. Ohio was one of two states where ...

Donald Trump's approval rating is net negative, according to averages from multiple polling aggregators. Trump's approval rating in the first year of both of his terms is lower than any other modern ...

President Donald Trump's approval ratings continue dipping in most polls as he wrapped up this week juggling major legal, diplomatic and political developments. On Friday, the Supreme Court agreed to ...

The shift, while small, is notable after months of stability in President Trump’s approval rating. Note: Data as of 5 p.m. Eastern time on Dec. 4. The New York Times By Ruth Igielnik and Tyler Pager ...

With less than a month remaining in 2025, President Donald Trump’s approval ratings continue to have slip compared to his ratings at the start of his second term earlier this year. According to The ...

WASHINGTON, Nov 18 (Reuters) - President Donald Trump's approval rating fell to 38%, the lowest since his return to power, with Americans unhappy about his handling of the high cost of living and the ...

The FDA has rejected Biohaven’s request for approval of a neurological disorder therapy, prompting the biopharma to reprioritize its pipeline in order to shrink its annual R&D spend by 60%. After a ...

President Trump’s overall job approval reached a new second-term low in the latest Economist/YouGov survey. The poll, conducted this past weekend, shows Trump 19 points underwater, with 39 percent of ...